CN114956927B - Preparation method of beta-halogenated olefine acid ester derivative - Google Patents
Preparation method of beta-halogenated olefine acid ester derivative Download PDFInfo
- Publication number
- CN114956927B CN114956927B CN202210713171.3A CN202210713171A CN114956927B CN 114956927 B CN114956927 B CN 114956927B CN 202210713171 A CN202210713171 A CN 202210713171A CN 114956927 B CN114956927 B CN 114956927B
- Authority
- CN
- China
- Prior art keywords
- halogenated
- compound
- beta
- acid ester
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002253 acid Substances 0.000 title claims abstract description 19
- 150000002148 esters Chemical class 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- -1 alpha-keto acid compound Chemical class 0.000 claims abstract description 47
- 238000006243 chemical reaction Methods 0.000 claims abstract description 44
- 238000000034 method Methods 0.000 claims abstract description 11
- 239000003054 catalyst Chemical class 0.000 claims abstract description 8
- 239000003960 organic solvent Substances 0.000 claims abstract description 7
- 239000003513 alkali Substances 0.000 claims abstract description 3
- 150000005826 halohydrocarbons Chemical class 0.000 claims abstract description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 84
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 64
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 53
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 claims description 52
- 150000001875 compounds Chemical class 0.000 claims description 37
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 36
- 239000003208 petroleum Substances 0.000 claims description 20
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 18
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 18
- 239000003480 eluent Substances 0.000 claims description 10
- 239000002585 base Substances 0.000 claims description 4
- 150000008282 halocarbons Chemical class 0.000 claims description 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 238000004440 column chromatography Methods 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 125000003944 tolyl group Chemical group 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 5
- 125000000524 functional group Chemical group 0.000 abstract description 4
- 238000005580 one pot reaction Methods 0.000 abstract description 3
- 239000000758 substrate Substances 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 2
- 239000000575 pesticide Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 1
- 239000012450 pharmaceutical intermediate Substances 0.000 abstract 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 56
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 32
- 239000005711 Benzoic acid Substances 0.000 description 28
- 235000010233 benzoic acid Nutrition 0.000 description 28
- 238000005481 NMR spectroscopy Methods 0.000 description 24
- 235000011181 potassium carbonates Nutrition 0.000 description 17
- 239000012043 crude product Substances 0.000 description 16
- 239000011259 mixed solution Substances 0.000 description 16
- 239000000047 product Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 8
- 238000004364 calculation method Methods 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 239000012044 organic layer Substances 0.000 description 8
- 238000007789 sealing Methods 0.000 description 8
- 238000010898 silica gel chromatography Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000000605 extraction Methods 0.000 description 7
- 230000010355 oscillation Effects 0.000 description 7
- BUADUHVXMFJVLH-UHFFFAOYSA-N 7-chloro-3-imidazol-1-yl-2H-1,2,4-benzotriazin-1-ium 1-oxide Chemical compound N1[N+](=O)C2=CC(Cl)=CC=C2N=C1N1C=CN=C1 BUADUHVXMFJVLH-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- UIIIPQVTXBPHTI-UHFFFAOYSA-N 2-(4-methylphenyl)-2-oxoacetic acid Chemical compound CC1=CC=C(C(=O)C(O)=O)C=C1 UIIIPQVTXBPHTI-UHFFFAOYSA-N 0.000 description 5
- UASZGGQRDGLTIQ-UHFFFAOYSA-N 2-(4-bromophenyl)-2-oxoacetic acid Chemical compound OC(=O)C(=O)C1=CC=C(Br)C=C1 UASZGGQRDGLTIQ-UHFFFAOYSA-N 0.000 description 3
- TUXYZHVUPGXXQG-UHFFFAOYSA-N 4-bromobenzoic acid Chemical compound OC(=O)C1=CC=C(Br)C=C1 TUXYZHVUPGXXQG-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- VTESCYNPUGSWKG-UHFFFAOYSA-N (4-tert-butylphenyl)hydrazine;hydrochloride Chemical compound [Cl-].CC(C)(C)C1=CC=C(N[NH3+])C=C1 VTESCYNPUGSWKG-UHFFFAOYSA-N 0.000 description 2
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 description 2
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 150000001345 alkine derivatives Chemical class 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- QPMJENKZJUFOON-PLNGDYQASA-N ethyl (z)-3-chloro-2-cyano-4,4,4-trifluorobut-2-enoate Chemical class CCOC(=O)C(\C#N)=C(/Cl)C(F)(F)F QPMJENKZJUFOON-PLNGDYQASA-N 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- BLQJIBCZHWBKSL-UHFFFAOYSA-L magnesium iodide Chemical compound [Mg+2].[I-].[I-] BLQJIBCZHWBKSL-UHFFFAOYSA-L 0.000 description 2
- 229910001641 magnesium iodide Inorganic materials 0.000 description 2
- LPNBBFKOUUSUDB-UHFFFAOYSA-N p-toluic acid Chemical compound CC1=CC=C(C(O)=O)C=C1 LPNBBFKOUUSUDB-UHFFFAOYSA-N 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 description 1
- PGRFXXCKHGIFSV-UHFFFAOYSA-N 1,1,1,2,2,3,3,4,4-nonafluoro-4-iodobutane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)I PGRFXXCKHGIFSV-UHFFFAOYSA-N 0.000 description 1
- NAMYKGVDVNBCFQ-UHFFFAOYSA-N 2-bromopropane Chemical compound CC(C)Br NAMYKGVDVNBCFQ-UHFFFAOYSA-N 0.000 description 1
- 238000005712 Baylis-Hillman reaction Methods 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- HIYUMYXSGIKHHE-UHFFFAOYSA-M bismuth trifluoromethanesulfonate Chemical compound [Bi+3].[O-]S(=O)(=O)C(F)(F)F HIYUMYXSGIKHHE-UHFFFAOYSA-M 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- KMGBZBJJOKUPIA-UHFFFAOYSA-N butyl iodide Chemical compound CCCCI KMGBZBJJOKUPIA-UHFFFAOYSA-N 0.000 description 1
- SBTSVTLGWRLWOD-UHFFFAOYSA-L copper(ii) triflate Chemical compound [Cu+2].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F SBTSVTLGWRLWOD-UHFFFAOYSA-L 0.000 description 1
- 238000006880 cross-coupling reaction Methods 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- PYLWMHQQBFSUBP-UHFFFAOYSA-N monofluorobenzene Chemical compound FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- JPJIEXKLJOWQQK-UHFFFAOYSA-K trifluoromethanesulfonate;yttrium(3+) Chemical compound [Y+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F JPJIEXKLJOWQQK-UHFFFAOYSA-K 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- CITILBVTAYEWKR-UHFFFAOYSA-L zinc trifluoromethanesulfonate Substances [Zn+2].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F CITILBVTAYEWKR-UHFFFAOYSA-L 0.000 description 1
- ZMLPZCGHASSGEA-UHFFFAOYSA-M zinc trifluoromethanesulfonate Chemical compound [Zn+2].[O-]S(=O)(=O)C(F)(F)F ZMLPZCGHASSGEA-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B41/00—Formation or introduction of functional groups containing oxygen
- C07B41/12—Formation or introduction of functional groups containing oxygen of carboxylic acid ester groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/584—Recycling of catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention relates to the technical field of organic synthesis, in particular to a preparation method of a beta-halogenated olefine acid ester derivative, which comprises the following steps: sequentially adding an alpha-keto acid compound, a halogenated alkyne compound and a catalyst into an organic solvent, and reacting at a certain temperature; then adding alkali and halohydrocarbon into a reaction system, and reacting at a certain temperature to obtain the beta-halogenated olefine acid ester derivative. The invention takes the alpha-keto acid compound and the halogenated alkyne compound as raw materials to prepare the beta-halogenated olefine acid ester under the condition of one-pot method, and the method has the advantages of high reaction yield, simple operation, high atom economy, good functional group compatibility and wide substrate application range. Provides a new synthetic route for the preparation of the beta-halogenated olefine acid ester derivative, can play an important role in the fields of active pharmaceutical intermediates, pesticides, material science and the like, and has great application value and potential in industrial production and scientific research.
Description
Technical Field
The invention relates to the technical field of organic synthesis, in particular to a preparation method of a beta-halogenated olefine acid ester derivative.
Background
The cross-coupling reactions of metal-catalyzed haloolefins have played an important role in building complex molecular structures over the last decades (Angew.Chem.Int.Ed.2017, 56,2;Chem.Rev.2016,116,12564). Halogenated olefins are widely used to build carbon-carbon bonds, carbon-nitrogen bonds, carbon-oxygen bonds, and the like in pharmaceutically active molecules. Thus, the synthesis of halogenated olefins is of great importance (Angew.Chem.Int.Ed.2012, 51,5062;Angew.Chem.Int.Ed.2011,50,6723).
Beta-haloolefine acid ester is an important halogenated olefine subclass, and related literature for synthesizing tetra-substituted beta-haloolefine acid ester derivatives is not reported at present. The usual method for preparing iodo-olefin derivatives mainly comprises the carbometallation/iodiphilic halogenation of a directing group-directed alkyne to prepare beta-haloalkenyl esters (J.Am. Chem. Soc.2000,122, 3228) and magnesium iodide (MgI) 2 ) The promoted reaction of beta-Hillman (Morita-Baylis-Hillman) synthesizes cis beta-halo olefins (Tetrahedron Lett.2015,56,3285). The existing methods for synthesizing iodo olefin derivatives have the defects of difficult raw material acquisition, multiple side reactions and the like. At present, a method for preparing the beta-halogenated enoate derivative with high efficiency and wide adaptability does not exist.
Disclosure of Invention
Aiming at the problems, the invention provides a preparation method of a beta-halogenated enoate derivative, which has the advantages of mild reaction conditions, simple operation, easily available raw materials, good compatibility of functional groups and wide application range of substrates.
In order to achieve the above purpose, the technical scheme adopted by the invention is as follows:
the preparation method of the beta-halogenated olefine acid ester derivative specifically comprises the following steps:
step A, sequentially adding an alpha-keto acid compound shown in a formula (II), a halogenated alkyne compound shown in a formula (III) and a catalyst into an organic solvent, and reacting at a certain temperature;
step B, continuously adding alkali and halohydrocarbon into a reaction system, reacting at a certain temperature, and purifying through post-treatment to obtain the beta-halogenated olefine acid ester derivative (I), wherein the reaction structural formula is shown as follows;
wherein R is 1 、R 2 Independently selected from any one of phenyl, substituted phenyl, C1-C6 alkyl, C1-C6 alkenyl; r is R 3 Independently selected from any one of halogen fluorine, chlorine, bromine and iodine.
Wherein C1-C6 alkyl refers to a straight or branched alkyl group having 1 to 6 carbon atoms, comprising: methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, n-hexylcyclohexyl, and the like;
C1-C6 alkenyl means a straight or branched carbon-carbon double bond containing substituent having 1 to 6 carbon atoms comprising: ethenyl, propenyl, butenyl, pentenyl, hexenyl, cyclohexenyl.
Preferably, in step a, the organic solvent comprises: toluene, fluorobenzene, benzotrifluoride, chlorobenzene, benzene, xylene, tetrahydrofuran, methanol, ethanol, acetonitrile, N-dimethylformamide, N-dimethylacetamide, dimethylsulfoxide and N-methylpyrrolidone.
Preferably, in step a, the catalyst comprises: boron trifluoride diethyl etherate, trifluoromethanesulfonic anhydride, p-toluenesulfonic acid, ferric chloride, bismuth trifluoromethanesulfonate, zinc trifluoromethanesulfonate, yttrium trifluoromethanesulfonate, copper trifluoromethanesulfonate, aluminum chloride, titanium tetrachloride.
Preferably, in step A, the molar ratio of the alpha-keto acid compound (II) to the haloalkyne compound (III) is 1 (1-3); the molar ratio of the alpha-keto acid compound (II) to the catalyst is 1 (0.05-1); the dosage ratio of the alpha-keto acid compound (II) to the organic solvent is 1mmol (2-15) mL.
Preferably, in step A, the reaction temperature is 25 to 120℃and the reaction time is 1 to 12 hours.
Preferably, in step B, the base comprises any one of potassium carbonate, potassium acetate, sodium carbonate, sodium acetate, sodium bicarbonate, potassium phosphate, sodium hydroxide, lithium carbonate, sodium hydroxide, potassium bicarbonate, triethylamine, 1, 8-diazabicyclo [5.4.0] undec-7-ene.
Preferably, in step B, the halogenated hydrocarbon comprises any one of methyl iodide, butyl iodide, perfluorobutyl iodide, 1, 4-diiodobutyl bromide, ethyl bromide, isopropyl bromide.
Preferably, in step B, the molar ratio of the alpha-keto acid compound (II) to the base is 1 (0.5-3); the ratio of the alpha-keto acid compound (II) to the halogenated hydrocarbon is 1 (5-15).
Preferably, in step B, the reaction temperature is from-30 to 25℃and the reaction time is from 1 to 12 hours.
Preferably, in the step B, the eluent used for column chromatography purification is a mixed solvent of petroleum ether and ethyl acetate, wherein the volume ratio of petroleum ether to ethyl acetate is (50-100): 1.
The invention has the beneficial effects that:
1. the invention adopts cheap and easily available alpha-keto acid compound and halogenated alkyne as raw materials, takes acid as a catalyst, and synthesizes the beta-halogenated olefine acid ester derivative by a one-pot method.
2. The invention can be operated under the air condition, is insensitive to water and oxygen, has mild reaction condition and is simple to operate.
3. The invention has the advantages of good compatibility of functional groups, simple post-treatment, high atom economy and the like.
4. The invention provides a new synthetic route for the preparation of the beta-halogenated olefine acid ester derivative, and the prepared beta-halogenated olefine acid ester derivative can play an important role in the fields of active drug intermediates, pesticide intermediates and the like, and has great application value and potential in industrial production and scientific research.
Detailed Description
The technical scheme of the present invention is further illustrated and described below by means of specific embodiments, but the embodiments of the present invention are not limited thereto.
Example 1:
adding the above formula of benzoic acid (II), iodoalkyne compound (III), and trifluoro-boric acid diethyl ether (BF) into toluene 3 ·Et 2 O), and then stirring and sealing at 40 ℃ for 2 hours. After the reaction system was cooled to 0 ℃, potassium carbonate and methyl iodide were added, and the reaction was continued for 12 hours.
Wherein the molar ratio of the benzoic acid (II) to the iodoalkyne compound (III) is 1:1.2; benzoic acid (II) and boron trifluoride diethyl etherate (BF) 3 ·Et 2 O) is 1:0.2; the ratio of benzoic acid (II) to toluene was 1mmol:4mL; the molar ratio of the benzoic acid (II) to the potassium carbonate is 1:2; the molar ratio of the benzoic acid (II) to the methyl iodide is 1:20.
After the reaction is finished, adding a mixed solution of ethyl acetate and saturated saline in equal volume ratio into a reaction system, carrying out oscillation extraction for 3 times, collecting an organic layer, drying, rotationally evaporating and concentrating to obtain a crude product, carrying out 300-mesh silica gel column chromatography on the crude product, and taking a mixed solution of ethyl acetate and petroleum ether as an eluent, wherein the volume ratio of the ethyl acetate to the petroleum ether is 1:20, thus obtaining a target product of the formula (I) compound (C 17 H 13 IO 3 )。
For the compound (C) of formula (I) obtained in this example 17 H 13 IO 3 ) Nuclear magnetic resonance analysis was performed, with the following results: 1 h NMR (400 MHz, deuterated chloroform CDCl) 3 )δ8.03–8.01(m,2H),7.63–7.59(m,1H),7.55–7.41(m,5H),7.39–7.37(m,2H),3.50(s,3H).
13 C NMR (100 MHz, deuterated chloroform CDCl) 3 )δ191.7,162.8,142.0,138.4,133.7,132.6,129.3(2C),128.9(2C),128.8(2C),128.7,128.4(2C),116.8,52.7.
Through calculation: compounds of formula (I) (C 17 H 13 IO 3 ) Yield of 83%, melting point: 110-112 ℃.
Example 2:
adding the above formula of benzoic acid (II), 4-methyl iodoalkyne compound (III), and trifluoro-boric acid diethyl ether (BF) into toluene 3 ·Et 2 O), and then stirring and sealing at 40 ℃ for 2 hours. After the reaction system was cooled to 0 ℃, potassium carbonate and methyl iodide were added, and the reaction was continued for 12 hours.
Wherein the molar ratio of the benzoyl formic acid (II) to the 4-methyl iodinated alkyne compound (III) is 1:1.2; benzoic acid (II) and boron trifluoride diethyl etherate (BF) 3 ·Et 2 O) is 1:0.2; the ratio of benzoic acid (II) to toluene was 1mmol:4mL; the molar ratio of the benzoic acid (II) to the potassium carbonate is 1:2; the molar ratio of the benzoic acid (II) to the methyl iodide is 1:20.
After the reaction is finished, adding a mixed solution of ethyl acetate and saturated saline in equal volume ratio into a reaction system, carrying out oscillation extraction for 3 times, collecting an organic layer, drying, rotationally evaporating and concentrating to obtain a crude product, carrying out 300-mesh silica gel column chromatography on the crude product, and taking a mixed solution of ethyl acetate and petroleum ether as an eluent, wherein the volume ratio of the ethyl acetate to the petroleum ether is 1:20, thus obtaining a target product of the formula (I) compound (C 18 H 15 IO 3 )。
For the compound (C) of formula (I) obtained in this example 18 H 15 IO 3 ) Nuclear magnetic resonance analysis was performed, with the following results: 1 h NMR (400 MHz, deuterated chloroform CDCl) 3 )δ7.92(d,J=8.1,2H),7.51–7.41(m,3H),7.40–7.35(m,2H),7.32(d,J=8.0,2H),3.51(s,3H),2.45(s,3H).
13 C NMR (100 MHz, deuterated chloroform CDCl) 3 )δ191.4,162.8,144.7,141.7,138.4,130.0,129.5(2C),129.4(2C),128.8(2C),128.7,128.4(2C),116.9,52.6,21.7.
Through calculation: compounds of formula (I) (C 18 H 15 IO 3 ) Yield of 78%, melting point: 110-112 ℃.
Example 3:
adding the above formula of benzoic acid (II), 4-bromoiodoalkyne compound (III), and trifluoro-boric acid diethyl ether (BF) into toluene 3 ·Et 2 O), and then stirring and sealing at 40 ℃ for 2 hours. After the reaction system was cooled to 0 ℃, potassium carbonate and methyl iodide were added, and the reaction was continued for 12 hours.
Wherein the molar ratio of the benzoyl formic acid (II) to the 4-bromoiodoalkyne compound (III) is 1:1.2; benzoic acid (II) and boron trifluoride diethyl etherate (BF) 3 ·Et 2 O) is 1:0.2; the ratio of benzoic acid (II) to toluene was 1mmol:4mL; the molar ratio of the benzoic acid (II) to the potassium carbonate is 1:2; the molar ratio of the benzoic acid (II) to the methyl iodide is 1:20.
After the reaction is finished, adding a mixed solution of ethyl acetate and saturated saline in equal volume ratio into a reaction system, carrying out oscillation extraction for 3 times, collecting an organic layer, drying, rotationally evaporating and concentrating to obtain a crude product, carrying out 300-mesh silica gel column chromatography on the crude product, and taking a mixed solution of ethyl acetate and petroleum ether as an eluent, wherein the volume ratio of the ethyl acetate to the petroleum ether is 1:20, thus obtaining a target product of the formula (I) compound (C 17 H 12 BrIO 3 )。
For the compound (C) of formula (I) obtained in this example 17 H 12 BrIO 3 ) Nuclear magnetic resonance analysis was performed, with the following results: 1 h NMR (400 MHz, deuterated chloroform CDCl) 3 )δ7.90–7.85(m,2H),7.67(m,2H),7.51–7.42(m,3H),7.38–7.34(m,2H),3.54(s,3H).
13 C NMR (100 MHz, deuterated chloroform CDCl) 3 )δ190.8,163.0,142.4,138.1,132.3(2C),131.5,130.7(2C),129.0,128.9,128.8(2C),128.5(2C),116.1,52.9.
Through calculation: compounds of formula (I) (C 17 H 12 BrIO 3 ) Yield of 82%, melting point: 120-122 ℃.
Example 4:
adding 4-methylbenzoyl formic acid (II), iodoalkyne compound (III) and trifluoro-boric acid diethyl ether (BF) into toluene 3 ·Et 2 O), and then stirring and sealing at 40 ℃ for 2 hours. After the reaction system was cooled to 0 ℃, potassium carbonate and methyl iodide were added, and the reaction was continued for 12 hours.
Wherein the molar ratio of the 4-methylbenzoyl formic acid (II) to the iodinated alkyne compound (III) is 1:1.2; 4-Methylbenzoic acid (II) with boron trifluoride diethyl etherate (BF) 3 ·Et 2 O) is 1:0.2; the ratio of 4-methylbenzoyl formic acid (II) to toluene was 1 mmol/4 mL; the molar ratio of the 4-methylbenzoyl formic acid (II) to the potassium carbonate is 1:2; the molar ratio of 4-methylbenzoyl formic acid (II) to methyl iodide is 1:20.
After the reaction is finished, adding a mixed solution of ethyl acetate and saturated saline in an equal volume ratio into a reaction system, carrying out oscillation extraction for 3 times, collecting an organic layer, drying, rotationally evaporating and concentrating to obtain a crude product, carrying out 300-mesh silica gel column chromatography on the crude product, and taking a mixed solution of ethyl acetate and petroleum ether as an eluent, wherein the volume ratio of the ethyl acetate to the petroleum ether is 1:20, thus obtaining a target product with white solid appearanceCompounds of formula (I) (C 18 H 15 IO 3 )。
For the compound (C) of formula (I) obtained in this example 18 H 15 IO 3 ) Nuclear magnetic resonance analysis was performed, with the following results: 1 h NMR (400 MHz, deuterated chloroform CDCl) 3 )δ8.04–7.99(m,2H),7.63–7.58(m,1H),7.54–7.50(m,2H),7.31–7.25(m,4H),3.50(s,3H),2.42(s,3H).
13 C NMR (100 MHz, deuterated chloroform CDCl) 3 )δ191.8,163.1,142.1,138.8,135.4,133.7,132.7,129.3(2C),129.2(2C),128.8(2C),128.7(2C),116.4,52.7,21.4.
Through calculation: compounds of formula (I) (C 18 H 15 IO 3 ) Yield of 81%, melting point: 148-150 ℃.
Example 5:
adding 4-bromobenzoyl formic acid (II), iodoalkyne compound (III), and trifluoro boric acid diethyl ether (BF) into toluene 3 ·Et 2 O), and then stirring and sealing at 40 ℃ for 2 hours. After the reaction system was cooled to 0 ℃, potassium carbonate and methyl iodide were added, and the reaction was continued for 12 hours.
Wherein the molar ratio of the 4-bromobenzoyl formic acid (II) to the halogenated alkyne compound (III) is 1:1.2; 4-bromobenzoic acid (II) and boron trifluoride diethyl etherate (BF) 3 ·Et 2 O) is 1:0.2; the ratio of 4-bromobenzoic acid (II) to toluene was 1 mmol/4 mL; the molar ratio of the 4-bromobenzoyl formic acid (II) to the potassium carbonate is 1:2; the molar ratio of 4-bromobenzoic acid (II) to methyl iodide is 1:20.
After the reaction is finished, adding a mixed solution of ethyl acetate and saturated saline in equal volume ratio into a reaction system, carrying out oscillation extraction for 3 times, collecting an organic layer, drying, rotationally evaporating and concentrating to obtain a crude product, carrying out 300-mesh silica gel column chromatography on the crude product, and taking a mixed solution of ethyl acetate and petroleum ether as an eluent, wherein the volume ratio of the ethyl acetate to the petroleum ether is 1:20, thus obtaining the product with the appearance of whiteTarget product of color solid compound (C) of formula (I) 17 H 12 BrIO 3 )。
For the compound (C) of formula (I) obtained in this example 17 H 12 BrIO 3 ) Nuclear magnetic resonance analysis was performed, with the following results: 1 h NMR (400 MHz, deuterated chloroform CDCl) 3 )δ8.02–7.97(m,2H),7.65–7.59(m,3H),7.52(m,2H),7.26(m,2H),3.51(s,3H).
13 C NMR (100 MHz, deuterated chloroform CDCl) 3 )δ191.5,162.5,141.1,137.2,133.8,132.5,131.8(2C),130.7(2C),129.3(2C),128.9(2C),123.1,117.5,52.8.
Through calculation: compounds of formula (I) (C 17 H 12 BrIO 3 ) Yield of 82%, melting point: 130-132 ℃.
Example 6:
adding the 2-thiopheneacetic acid compound (II), the iodoalkyne compound (III) and the trifluoro-boric acid diethyl ether (BF) into toluene 3 ·Et 2 O), and then stirring and sealing at 40 ℃ for 2 hours. After the reaction system was cooled to 0 ℃, potassium carbonate and methyl iodide were added, and the reaction was continued for 12 hours.
Wherein the molar ratio of the 2-thiopheneacetic acid compound (II) to the halogenated alkyne compound (III) is 1:1.2; 2-thiopheneacetic acid compound (II) and boron trifluoride diethyl etherate (BF 3 ·Et 2 O) is 1:0.2; the ratio of the 2-thiopheneacetic acid compound (II) to toluene is 1 mmol/4 mL; the molar ratio of the 2-thiopheneacetic acid compound (II) to the potassium carbonate is 1:2; the molar ratio of the 2-thiopheneacetic acid compound (II) to methyl iodide is 1:20.
After the reaction is finished, adding a mixed solution of ethyl acetate and saturated saline with equal volume ratio into a reaction system, oscillating and extracting for 3 times, collecting an organic layer, drying, rotationally evaporating and concentrating to obtain a crude product, subjecting the crude product to 300-mesh silica gel column chromatography, and using the mixed solution of ethyl acetate and petroleum ether as an eluent, wherein the ethyl acetate and the petroleum ether are mixed into a solid phase, and the solid phase is prepared by the steps ofThe volume ratio is 1:20, and the target product of the compound (C) with the formula (I) is obtained 15 H 11 IO 3 S)。
For the compound (C) of formula (I) obtained in this example 15 H 11 IO 3 S) performing nuclear magnetic resonance analysis, wherein the result is as follows: 1 h NMR (400 MHz, deuterated chloroform CDCl) 3 )δ8.03–8.01(m,2H),7.63–7.59(m,1H),7.55–7.41(m,5H),7.39–7.37(m,2H),3.50(s,3H).
13 C NMR (100 MHz, deuterated chloroform CDCl) 3 )δ191.7,162.8,142.0,138.4,133.7,132.6,129.3(2C),128.9(2C),128.8(2C),128.7,128.4(2C),116.8,52.7.
Through calculation: compounds of formula (I) (C 15 H 11 IO 3 S) yield 73%, melting point: 94-96 ℃.
Example 7:
adding the above formula of benzoic acid (II), bromoalkyne compound (III), and trifluoro-boric acid diethyl ether (BF) into toluene 3 ·Et 2 O), and then stirring and sealing at 40 ℃ for 2 hours. After the reaction system was cooled to 0 ℃, potassium carbonate and methyl iodide were added, and the reaction was continued for 12 hours.
Wherein the molar ratio of the benzoic acid (II) to the bromoalkyne compound (III) is 1:1.2; benzoic acid (II) and boron trifluoride diethyl etherate (BF) 3 ·Et 2 O) is 1:0.2; the ratio of benzoic acid (II) to toluene was 1mmol:4mL; the molar ratio of the benzoic acid (II) to the potassium carbonate is 1:2; the molar ratio of the benzoic acid (II) to the methyl iodide is 1:20.
After the reaction is finished, adding a mixed solution of ethyl acetate and saturated saline in equal volume ratio into a reaction system, carrying out oscillation extraction for 3 times, collecting an organic layer, drying, rotationally evaporating and concentrating to obtain a crude product, carrying out 300-mesh silica gel column chromatography on the crude product, and taking the mixed solution of ethyl acetate and petroleum ether as an eluent, wherein the volume ratio of the ethyl acetate to the petroleum ether is 1:20 to obtainTo the target product compound of formula (I) (C) as a white solid in appearance 17 H 13 BrO 3 )。
For the compound (C) of formula (I) obtained in this example 17 H 13 BrO 3 ) Nuclear magnetic resonance analysis was performed, with the following results: 1 h NMR (400 MHz, deuterated chloroform CDCl) 3 )δ8.03–8.00(m,2H),7.65–7.61(m,1H),7.55–7.53(m,2H),7.50–7.41(m,5H),3.54(s,3H).
13 C NMR (100 MHz, deuterated chloroform CDCl) 3 )δ189.9,164.4,136.5,134.9,133.9,133.8133.3,129.3(2C),129.1(2C),128.9(2C),128.8,128.4(2C),52.8.
Through calculation: compounds of formula (I) (C 17 H 13 BrO 3 ) Yield of 80%, melting point: 92-94 ℃.
Example 8:
adding the above formula of benzoic acid (II), chloroalkyne compound (III), and trifluoro-boric acid diethyl ether (BF) into toluene 3 ·Et 2 O), and then stirring and sealing at 40 ℃ for 2 hours. After the reaction system was cooled to 0 ℃, potassium carbonate and methyl iodide were added, and the reaction was continued for 12 hours.
Wherein the molar ratio of the benzoic acid (II) to the chloroalkyne compound (III) is 1:1.2; benzoic acid (II) and boron trifluoride diethyl etherate (BF) 3 ·Et 2 O) is 1:0.2; the ratio of benzoic acid (II) to toluene was 1mmol:4mL; the molar ratio of the benzoic acid (II) to the potassium carbonate is 1:2; the molar ratio of the benzoic acid (II) to the methyl iodide is 1:20.
After the reaction is finished, adding a mixed solution of ethyl acetate and saturated saline in equal volume ratio into a reaction system, carrying out oscillation extraction for 3 times, collecting an organic layer, drying, rotationally evaporating and concentrating to obtain a crude product, carrying out 300-mesh silica gel column chromatography on the crude product, and taking a mixed solution of ethyl acetate and petroleum ether as an eluent, wherein the volume ratio of the ethyl acetate to the petroleum ether is 1:20, thus obtaining the white solidThe target product of the body is a compound (C) 17 H 13 ClO 3 )。
For the compound (C) of formula (I) obtained in this example 17 H 13 ClO 3 ) Nuclear magnetic resonance analysis was performed, with the following results: 1 h NMR (400 MHz, deuterated chloroform CDCl) 3 )δ8.02–7.99(m,2H),7.64–7.61(m,1H),7.54–7.51(m,2H),7.49–7.40(m,5H),3.54(s,3H).
13 C NMR (100 MHz, deuterated chloroform CDCl) 3 )δ189.4,164.9,140.5,134.0,133.8,133.5,132.9,129.3(2C),129.2(2C),128.9(3C),128.3(2C),52.6.
Through calculation: compounds of formula (I) (C 17 H 13 ClO 3 ) Yield of 84%, melting point: 74-76 ℃.
In summary, the invention takes the alpha-keto acid compound and the halogenated alkyne compound as raw materials to prepare the beta-halogenated olefine acid ester under the condition of one-pot method, and the method has the advantages of high reaction yield, simple operation, high atom economy, good functional group compatibility and wide substrate application range, and provides a brand-new route for preparing the beta-halogenated olefine acid ester derivative.
It should be noted that, not described in detail, the present invention is well known to those skilled in the art.
The above embodiments are only for further illustrating the embodiments of the present invention, but the present invention is not limited to the above embodiments, and all the equivalent changes and modifications made in the above embodiments are included in the scope of the present invention according to the technical spirit of the present invention.
Claims (4)
1. The preparation method of the beta-halogenated olefine acid ester derivative is characterized by comprising the following steps of:
step A, sequentially adding an alpha-keto acid compound shown in a formula (II), a halogenated alkyne compound shown in a formula (III) and a catalyst into an organic solvent, and reacting at a certain temperature;
step B, continuously adding alkali and halohydrocarbon into a reaction system, reacting at a certain temperature, and purifying through post-treatment to obtain the beta-halogenated olefine acid ester derivative (I), wherein the reaction structural formula is shown as follows;
wherein R is 1 、R 2 Independently selected from any one of phenyl, C1-C6 alkyl; r is R 3 Independently selected from any one of halogen fluorine, chlorine, bromine and iodine;
in step a, the organic solvent is toluene;
in the step A, boron trifluoride diethyl etherate is used as a catalyst;
in step B, the base is potassium carbonate;
in step B, the halogenated hydrocarbon is methyl iodide.
2. The process for producing a β -haloenoate derivative according to claim 1, wherein in step a, the molar ratio of the α -keto acid compound (II) to the haloalkyne compound (III) is 1 (1-3); the molar ratio of the alpha-keto acid compound (II) to the catalyst is 1 (0.05-1); the dosage ratio of the alpha-keto acid compound (II) to the organic solvent is 1mmol (2-15) mL.
3. The process for producing a β -haloenoate derivative according to claim 1, wherein in step B, the molar ratio of the α -keto acid compound (II) to the base is 1 (0.5-3); the ratio of the alpha-keto acid compound (II) to the halogenated hydrocarbon is 1 (5-15).
4. The process for producing a β -haloenoate derivative according to claim 1, wherein in step B, the eluent used for column chromatography purification is a mixed solvent of petroleum ether and ethyl acetate, wherein the volume ratio of petroleum ether to ethyl acetate is (50-100): 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210713171.3A CN114956927B (en) | 2022-06-22 | 2022-06-22 | Preparation method of beta-halogenated olefine acid ester derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210713171.3A CN114956927B (en) | 2022-06-22 | 2022-06-22 | Preparation method of beta-halogenated olefine acid ester derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114956927A CN114956927A (en) | 2022-08-30 |
CN114956927B true CN114956927B (en) | 2024-01-30 |
Family
ID=82966159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210713171.3A Active CN114956927B (en) | 2022-06-22 | 2022-06-22 | Preparation method of beta-halogenated olefine acid ester derivative |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114956927B (en) |
-
2022
- 2022-06-22 CN CN202210713171.3A patent/CN114956927B/en active Active
Non-Patent Citations (1)
Title |
---|
Highly Stereoselective Gold-Catalyzed Coupling of Diazo Reagents and Fluorinated Enol Silyl Ethers to Tetrasubstituted Alkenes;Fu-Min Liao 等;《Communication》;2459-2463 * |
Also Published As
Publication number | Publication date |
---|---|
CN114956927A (en) | 2022-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112521282A (en) | Bepaidic acid intermediate and synthesis method thereof | |
CN114634482B (en) | Diazonium difluoro methylation reagent and synthetic method and application thereof | |
CN114591194A (en) | Para-functional arylamine compound and synthesis method thereof | |
EP1700855B1 (en) | A process for the preparation of tazarotene | |
CN114956927B (en) | Preparation method of beta-halogenated olefine acid ester derivative | |
WO2020207129A1 (en) | Preparation and use of an ammonium salt | |
Zhao et al. | FeCl3· 6H2O-catalyzed synthesis of β-ketothioesters from chain α-oxo ketene dithioactals | |
CN112645841A (en) | 2-fluorobenzonitrile derivative and preparation method and application thereof | |
US5554764A (en) | Preparation of pyrrol and oxazole compounds: formation of C-acyl-α-amino acid esters therefrom | |
CN110294708B (en) | Preparation method of trifluoroethylselenophenanthridine and 3, 4-dihydroisoquinoline derivatives | |
CN115043799B (en) | Preparation method of 5, 6-dihydrobenzofuranone derivative | |
Richter et al. | Synthesis of muscalure and homologous hydrocarbons | |
WO2020127156A1 (en) | Improved synthesis of an epoxidation-catalyst | |
CN113461659B (en) | C-spirocyclic prostaglandin analogue intermediate and preparation method thereof | |
US5672717A (en) | Preparation of pyrrol and oxazole compounds; formation of porphyrins and C-acyl-α-amino acid esters therefrom | |
CN114805289B (en) | Preparation method of 1, 4-oxathia-3, 5-dialdehyde cyclohexadiene compound | |
CN110372718B (en) | Difluoromethane thiochromanonthiophene compound and preparation method thereof | |
CN114874167A (en) | Preparation method of 5-hydroxyfuranone derivative | |
CN111848552B (en) | Preparation method and application of 3- (substituted phenyl) oxetane-3-carboxylic acid and intermediate thereof | |
CN113493386B (en) | Novel high-selectivity asymmetric synthesis process of 2-fluorocyclopropylamine | |
CN114411182A (en) | Method for synthesizing alpha-carbonyl sulfoxide ylide dichloride under electrocatalysis | |
Cui et al. | Direct Double Electrophilic Fluorination of Allenoic Acids and Tosylamides to Give 1, 1‐Difluoroallylic Heterocyclic Compounds | |
JPH07324081A (en) | Production of dihalogenated prostacyclins | |
CN118027091A (en) | Preparation method of treprostinil and intermediate thereof | |
CN113480429A (en) | Synthetic method of alpha-fluoroacrylate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |